Tacrolimus Alkaline Phosphatase Conjugate

Product Description

Tacrolimus Alkaline Phosphatase Conjugate
Catalog number: B2010725
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.1 mg
Molecular Weight or Concentration: 0.2 mg/mL
Supplied as: Liquid
Applications: tools for the research and development of assays for the detection of Tacrolimus
Storage: -20C
Keywords: Tacrolimus-ALP, Tacrolimus-AP, Tacrolimus-Alkaline Phosphatase
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: First MR, Fitzsimmons WE. Modified release tacrolimus Yonsei Med J. 2004 Dec 31;45(6):1127-31.
2: Jouve T, Noble J, Rostaing L, Malvezzi P. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization Expert Opin Drug Saf. 2019 Apr;18(4):285-294.
3: Kalt DA. Tacrolimus: A Review of Laboratory Detection Methods and Indications for Use Lab Med. 2017 Nov 8;48(4):e62-e65.
4: Zhai J, Gu J, Yuan J, Chen J. Tacrolimus in the treatment of ocular diseases BioDrugs. 2011 Apr 1;25(2):89-103.
5: Tacrolimus Am J Health Syst Pharm. 2001 Dec 15;58(24):2376-7.
6: Uemoto S. [Tacrolimus] Nihon Rinsho. 2005 May;63 Suppl 5:673-7.
7: Radhakrishnan A, Kuppusamy G, Ponnusankar S, Mutalik S. Towards next-generation personalization of tacrolimus treatment: a review on advanced diagnostic and therapeutic approaches Pharmacogenomics. 2021 Nov;22(17):1151-1175.
8: Schreiber SL. The Rise of Molecular Glues Cell. 2021 Jan 7;184(1):3-9.
9: Pennington CA, Park JM. Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients Am J Health Syst Pharm. 2015 Feb 15;72(4):277-84.
10: Zhang X, Lin G, Tan L, Li J. Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations Biomed Pharmacother. 2018 Jun;102:107-114.

Products Related to Tacrolimus Alkaline Phosphatase Conjugate: Conjugates